The TSX has long been a treasure trove for investors seeking high-growth opportunities in small-cap stocks. While these companies often fly under the radar, their balance sheets, operational milestones, and market positioning can reveal compelling value. In July 2025, three names stand out: InnoCan Pharma (CVE: INOC), Amerigo Resources (CVE: AMR), and Graphite One (TSX-V: GPH). Each offers a unique blend of resilience, innovation, and strategic momentum, making them worth a closer look for those willing to dig into the details.
InnoCan Pharma: From Operating Losses to Breakthroughs
InnoCan Pharma’s Q1 2025 results signal a dramatic turnaround. Revenue rose 15% year-over-year to $7.8 million, driven by its subsidiary BI Sky Global. More impressively, the company transitioned from a $1.2 million operating loss in Q1 2024 to a $0.5 million profit in Q1 2025—a 140% reduction in losses. This shift reflects disciplined cost…
